Good news for CA providers and residents! Starting July 1, 2024, Pharmacogenomic (PGx) biomarker testing will be a covered benefit for all Californians*, regardless of insurance provider. PGx testing is…
Read More
Professor David Kisor saw a need for more pharmacogenomic education for pharmacists, and he wanted to fill it. Dr. Kisor, PharmD, serves as professor and chair of pharmaceutical sciences at…
Read More
More work seems needed to better familiarize physicians with the concept of pharmacogenomic testing, according to the results of a recent study. The study in the August edition of Pharmacogenomics and Personalized Medicine found that just…
Read More
